| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |